← Back to headlines
Egypt’s Minapharm Secures $16.5 Million to Develop New Ebola Vaccine
The Egyptian pharmaceutical company Minapharm has received significant funding to advance research and production of a novel vaccine targeting the ongoing Ebola outbreak.
28 Aug, 10:17 — 28 Aug, 10:17
Sources
Showing 1 of 1 sources



